Composition for the treatment of refractory painful intervertebral disc related disorders and method for delivery thereof to treat thereto
The present application discloses a composition for the treatment of Painful Damaged Disc Syndrome (PDDS), disc bulge, protrusion and herniation, and a delivery method and recommended treatment protocol for delivering thereto to a subject with an effective dosage of the composition. The composition has anti-inflammatory, antioxidant and vasodilating and antispasmodic properties. The compound is being administered via intravenous drip over a specified period for pain relief.
1. A method for providing a treatment to a patient diagnosed with painful damaged disc syndrome (PDDS), the method comprising:
selecting a patient for treatment based on the fact he/she presents with chronic or acute pain for greater than or equal to 3 months;
performing a history and physical studies, the history and physical studies comprising bloodwork and radiographic images to include medical history past and present, medications—past and present, and bloodwork including CBC with differential and platelet count, liver function, kidney function and electrolyte balance;
introducing treatment to the patient if radiographic evidence of PDDS is present and bloodwork is acceptable;
introducing the treatment to the patient by a plurality of steps further comprising:
preparing an IV bag with a compound within a 2-hour time limit from the arrival of the patient, the compound comprising at least 1 mg of colchicine as an anti-inflammatory, and 1000 mg of magnesium chloride as an antioxidative, vasodilating, antispasmodic and anti-inflammatory agent;
obtaining consent prior to insertion of a catheter;
inserting and securing the catheter to prevent accidental infiltration or extravasation of the magnesium into a subcutaneous tissue; and
initiating a treatment schedule immediately after the first session and followed as closely as feasible based on the patient's results and needs.